STOCKHOLM, Aug. 18, 2022 /PRNewswire/ — European approval for Kinpeygo® “On May 19th, the European Medicines Agency (EMA) announced that it had adopted a positive opinion regarding the application for conditional approval of Kinpeygo® for the treatment of IgA nephropathy, and on July…